The cardiac arrhythmia suppression trial: First CAST … then CAST-II
Authors:
- Dan M. RodenDRDan M. Roden
- Richard J. KatzRKRichard J. Katz
- Raymond L. WoosleyRWRaymond L. Woosley
- David M. SalernoDSDavid M. Salerno
- Richard W. HenthornRHRichard W. Henthorn
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarctionThe American Journal of Cardiology, 1986
- Flecainide versus quinidine: Results of a multicenter trialThe American Journal of Cardiology, 1984
- Effect of antiarrhythmic drugs on mortality after myocardial infarctionThe American Journal of Cardiology, 1983
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983
- Adverse reactions to quinidine in hospitalized patients: Findings based on data from the boston collaborative drug surveillance programProgress in Cardiovascular Diseases, 1977
- ORAL DISOPYRAMIDE IN PROPHYLAXIS OF ARRHYTHMIAS FOLLOWING MYOCARDIAL INFARCTIONThe Lancet, 1976
- Long-Term Use of Procaine Amide following Acute Myocardial InfarctionCirculation, 1973
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971